- Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report
-
Han JE, Cho HJ, Kim SS, Cheong JY
- KMID: 2520904
- J Liver Cancer.
- 2021 Sep;21(2):169-176.
- doi: 10.17998/jlc.2021.08.26
The current Food and Drug Administration-approved systemic treatments for advanced hepatocellular carcinoma (HCC) include multikinase inhibitors (tyrosine kinase inhibitor [TKI]) and immune checkpoint inhibitors (ICIs). Among ICIs, nivolumab is used... -
- CITED
-
- Close
- SHARE
-
- Close
- Sorafenib-induced Pancreatic Pseudocyst in a Patient with Advanced Hepatocellular Carcinoma: a Rare Adverse Event
-
Kim DH, Kim M, Yim HJ, Suh SJ, Jung YK
- KMID: 2463617
- J Liver Cancer.
- 2019 Sep;19(2):154-158.
- doi: 10.17998/jlc.19.2.154
A 54-year old man diagnosed with advanced hepatocellular carcinoma began treatment with sorafenib. After 3 weeks of treatment, he complained of abdominal pain and nausea. Abdominal sonography showed multiple hepatic... -
- CITED
-
- Close
- SHARE
-
- Close
- The Genomic Landscape and Its Clinical Implications in Hepatocellular Carcinoma
-
Yim SY, Lee JS
- KMID: 2463610
- J Liver Cancer.
- 2019 Sep;19(2):97-107.
- doi: 10.17998/jlc.19.2.97
The pathogenesis of hepatocellular carcinoma (HCC) is a complex process. During the last decade, advances in genomic technologies enabled delineation of the genomic landscape of HCC, resulting in the identification... -
- CITED
-
- Close
- SHARE
-
- Close
- Liver Transplantation for Advanced Hepatocellular Carcinoma
-
Lee KW, Suh KS
- KMID: 2202217
- J Korean Soc Transplant.
- 2010 Mar;24(1):4-12.
- doi: 10.4285/jkstn.2010.24.1.4
Hepatocellular carcinoma (HCC) has become an important indication for liver transplantation in Korea. Even though the Milan criteria have been accepted as the gold standard in deceased donor liver transplantation,... -
- CITED
-
- Close
- SHARE
-
- Close
- Expanded Criteria for Living Donor Liver Transplantation in Patients with Advanced Hepatocellular Carcinoma
-
Lee KK, Youn YC, Hwang JK, Park JH, Kim JI, Yoo YK, Moon IS, Kim DG
- KMID: 2083319
- Korean J Hepatobiliary Pancreat Surg.
- 2009 Sep;13(3):171-178.
PURPOSE: The purpose of this study was to evaluate the possibility of expanding the indication for living donor liver transplantation (LDLT) for treatment of hepatocellular carcinoma (HCC), beyond the Milan... -
- CITED
-
- Close
- SHARE
-
- Close
- High dose regional chemotherapy in advanced hepatocellular carcinoma with 4-lumen-2-balloon catheter
-
Hwang YJ, Kim JW, Kim YI
- KMID: 2244359
- Korean J Hepatobiliary Pancreat Surg.
- 2000 Oct;4(2):101-106.
BACKGROUND: Surgical resection is the mainstay for treatment of HCC. However, resction is often not feasible in patients with advanced HCC. Patients excluded from surgery, may be treated with systemic... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Study of AP (Doxorubicin, Cisplatin) Chemotherapy in Patients with Advanced Hepatocellular Carcinoma
-
Lee JA, Kang YK, Kim CM, Lee JO, Kang TW
- KMID: 1531923
- J Korean Cancer Assoc.
- 1997 Feb;29(1):103-110.
PURPOSE: Hepatocellular carcinoma (HCC) is the most common form of primary hepatic carcinoma and is considered to be a highly malignant tumor with poor prognosis. We evaluated the efficacy and... -
- CITED
-
- Close
- SHARE
-
- Close
